Contineum Therapeutics, Inc. Class A Common Stock
Earnings Date & Report
Last updated:
Contineum Therapeutics, Inc. Class A Common Stock’s last earnings date was on 16 May 2024. It reported its quarterly earnings per share (EPS) reaching -$3.55, falling behind the estimated value of -$0.46 by $3.09.
Contineum Therapeutics, Inc. Class A Common Stock stock Earnings report, Estimates & History
| 2024-05-16 | -0.46 | -3.55 |
|---|
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Contineum Therapeutics, Inc. Class A Common Stock stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 16 May 2024 | Missed | -$0.46 | -$3.55 | N/A | N/A | |
Contineum Therapeutics, Inc. Class A Common Stock Earnings report FAQs
When is Contineum Therapeutics, Inc. Class A Common Stock's next Earnings date?
The company has not set the next earnings date yet.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.